AbbVie Inc

ABBV(AbbVie Inc)

$263.69+0.14%

ABBV(AbbVie Inc) Price Prediction Summary

AI-Generated
As of September 17, 2026, ABBV is displaying bullish technical conditions with all major moving averages aligned upward and MACD confirming momentum. The 20/50/200-day stack remains intact, supporting further upside, while RSI at 57.323 leaves room for continued appreciation without yet reaching overbought levels. Sentiment and market structure data are unavailable, leaving uncertainty around broader positioning and fund flows—key variables to monitor for confirmation of the technical bias. Watch SMA20 support and potential resistance around the prior highs; sustained strength above 259.50 would reinforce the bullish setup.
Technical Indicators
Short-Term Bullish

Moving averages aligned bullish, MACD confirming upside, RSI holding mid-range with room to run higher.

Key Trading Levels

How Gate Predicts ABBV(AbbVie Inc) Price

Multi-Source Data Collection

Three independent data sources—technical indicators, market sentiment, and market structure signals—are integrated in real time, covering price behavior, trader behavior, and supply-demand dynamics, ensuring the analysis does not rely on a single dimension.

Independent Analysis by Dimension

Technical indicators are used to identify trends and structural positions, market sentiment is used to assess risk appetite, and market structure signals are used to identify supply-demand and positioning changes. Each dimension independently generates signals within its most appropriate time frame.

Cross-Validation of Composite Signals

When signals across multiple dimensions align, confidence in the assessment increases; when signals diverge, it indicates a transitional or consolidation phase, helping to avoid being misled by a single indicator.

Technical Indicators

AI-GeneratedAs of September 17, 2026, **ABBV technical analysis** shows a cleanly bullish setup on the daily timeframe. The 20-day, 50-day, and 200-day simple moving averages are stacked in ascending order—SMA20 at 259.50, SMA50 at 255.04, and SMA200 at 229.40—a textbook alignment that favors continued upward momentum. Both the shorter-term and intermediate-term averages remain above the long-term trend line, reinforcing structural strength. MACD is trading at 1.8343 with a Buy signal intact, confirming that momentum remains in the bulls\' favor without yet reaching overbought extremes. The RSI at 57.323 sits in neutral territory, neither overbought nor oversold, which suggests there is still room for price appreciation before running into supply exhaustion. The ABBV price forecast benefits from this convergence: no technical divergence is present, and the overall signal is one of continuation. Watch for a break above the SMA20 as the key near-term level; sustained closes below SMA50 would signal a shift in the near-term outlook.
IndicatorValueSignal
Exponential Moving Average (10)259.8835
Buy
Exponential Moving Average (100)243.7981
Buy
Exponential Moving Average (20)258.4208
Buy
Exponential Moving Average (200)232.8472
Buy
Exponential Moving Average (30)256.9175
Buy
Exponential Moving Average (50)252.9805
Buy
Hull Moving Average (9)265.5268
Sell
Ichimoku Base Line (9, 26, 52, 26)256.2425
neutral
Moving Averages Summary
neutral
Simple Moving Average (10)257.982
Buy
Simple Moving Average (100)238.465
Buy
Simple Moving Average (20)259.579
Buy
Simple Moving Average (200)229.409
Buy
Simple Moving Average (30)256.7937
Buy
Simple Moving Average (50)255.0698
Buy
Volume Weighted Moving Average (20)259.3931
Buy
Average Directional Index (14)17.7437
neutral
Awesome Oscillator5.7393
neutral
Bull Bear Power6.7658
neutral
Commodity Channel Index (20)67.8554
neutral
MACD Level (12, 26)1.9579
Buy
Momentum (10)2.3
Sell
Oscillators Summary
neutral
Relative Strength Index (14)59.0125
neutral
Stochastic %K (14, 3, 3)90.7066
neutral
Stochastic RSI Fast (3, 3, 14, 14)94.8026
neutral
Ultimate Oscillator (7, 14, 28)66.5379
neutral
Williams Percent Range (14)-4.3792
neutral
Technical Summary
neutral

Market Sentiment

AI-GeneratedNo data yet
Analyst Rating
--
Options Put/Call Ratio
23.0400%
Implied Volatility (IV)
37.2913

Influencing Factors

Corporate Earnings and Profit Growth

Revenue, net profit, and forward guidance are the core factors affecting stock prices.

Industry Competition Landscape and Market Share

Changes in a company's competitiveness within the industry and its market share will impact its long-term valuation.

Overall Market Valuation and Interest Rate Environment

When interest rates rise or overall market valuations are elevated, individual stocks are more likely to experience pullbacks.

Institutional Funds and Market Sentiment

Large-scale institutional inflows or outflows, along with changes in market risk appetite, can amplify stock price volatility.

FAQ

What data is used to generate the ABBV(AbbVie Inc) price prediction?

x

ABBV(AbbVie Inc) price prediction is typically based on three types of data: technical indicators (e.g., RSI, MACD, moving averages), market sentiment (e.g., capital flows and derivatives data), and market structure signals (e.g., positioning and supply-demand changes). Multi-dimensional data is used to enhance the completeness of the analysis.

How do supply and demand affect the ABBV(AbbVie Inc) price prediction?

x

How are technical indicators used in the ABBV(AbbVie Inc) price prediction?

x

What role does market sentiment play in the ABBV(AbbVie Inc) price prediction?

x

What common factors can influence the ABBV(AbbVie Inc) price prediction?

x

How can price predictions be used to assess the current market state of ABBV(AbbVie Inc)?

x

Disclaimer

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.

Risk Warning

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Disclosure.